Overview

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer

Status:
Completed
Trial end date:
2003-08-29
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as gemcitabine and irinotecan, work in different ways to stop tumor cells from dividing so they stop growing or die. Combining radiation therapy with chemotherapy may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy and radiation therapy in treating patients who have locally advanced, unresectable pancreatic cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Wake Forest Baptist Health
Wake Forest University Health Sciences
Collaborator:
National Cancer Institute (NCI)
Treatments:
Gemcitabine
Irinotecan